Pure Biologics Spólka Akcyjna (PUR) — Cash Flow Reinvestment Rate

Latest as of March 2024: 0.05x

Pure Biologics Spólka Akcyjna (PUR) has a Cash Flow Reinvestment Rate of 0.05x as of March 2024, reinvesting zł96.00K (capex zł85.00K plus investments zł-11.00K) from operating cash flow of zł2.04 Million. Explore Pure Biologics Spólka Akcyjna (PUR) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

zł96.00K
Capex + Investments

Operating Cash Flow

zł2.04 Million
PLN

Capital Expenditures

zł85.00K
PLN

Pure Biologics Spólka Akcyjna Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Pure Biologics Spólka Akcyjna across 1 annual periods. Also explore how large is Pure Biologics Spólka Akcyjna's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Pure Biologics Spólka Akcyjna (2019–2019)

Year-by-year capital reinvestment analysis for Pure Biologics Spólka Akcyjna. For live market cap and broader valuation context, see how much is Pure Biologics Spólka Akcyjna worth.

Year Reinvestment Rate Total Reinvested (PLN) Operating CF Capex YoY Change
2019 5.24x zł27.97 Million zł5.33 Million zł161.92K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow